At the Forefront of Groundbreaking Research
RMA of New York is recognized as a global leader in providing the highest-quality, most advanced in vitro fertilization (IVF) technology available today. RMA of New York is at the forefront of groundbreaking research in infertility and reproductive medicine, and is committed to advancing science for the treatment of infertility.
A wide variety of fertility treatments are available for individuals seeking care from an RMA of New York reproductive specialist, and range from basic infertility care to the most progressive techniques in assisted reproductive technology.
National Recognition for RMA of New York
RMA of New York has achieved national recognition for clinical excellence and advanced research in the field of reproductive medicine. The physicians, nurses, embryologists, and research professionals have published hundreds of scientific journals, clinical abstracts and peer-reviewed articles, and have received awards from Patient Advocacy Organizations, the American Society of Reproductive Medicine (ASRM), Ivy League Institutions, and several of the top medical schools in the country. They are actively involved in numerous clinical studies and FDA trials, and have partnered with some of the world’s most advanced IVF technology innovators to vastly improve treatment for the millions of individuals currently facing infertility.
Current Research Studies:
Comprehensive Infertility Behavior Study
To participate in one of our ongoing clinical studies which will improve the means in which treatments are offered, please inquire with our Director of Research Operations, Joseph Lee, at [email protected] or 212-756-5777 ext. 314
“The reproductive journey is different now than it was 20 years ago, 10 years ago, and will be months from now. By analyzing big data, accessing machine learning algorithms and artificial intelligence, focusing on genomic and personalized medicine, and ultimately relying on compassionate and consistent clinical care, physicians can improve reproductive outcomes for their patients. We are proud to contribute to science, and look forward to participating in the advancement of the field of reproductive medicine for years to come.”